Collom & Carney Clinic ACO, LLC
CMS Shared Savings Program ACO Reporting


  ACO Name and Location
   
  Collom & Carney Clinic ACO, LLC
  5002 Cowhorn Creek Rd.
  Texarkana, TX 75503-9766

  ACO Primary Contact
 
Primary Contact NamePriscilla A. Newton
Primary Contact Phone Number903-614-3395
Primary Contact Email Addresspnewton@collom-carney.com

  Organization Information
  ACO participants:
 
 
ACO ParticipantsACO Participants in Joint Venture (Enter Y or N)
Collom & Carney ClinicN
 
  ACO governing body:
 
MemberMember's Voting PowerMembership TypeACO Participant TIN Legal Business Name/DBA, if Applicable
Last NameFirst NameTitle/Position
WomackJosephPhysician/Chairman14.28571429%ACO Participant RepresentativeCollom & Carney Clinic Association
WongPuiSumPhysician/Secretary14.28571429%ACO Participant RepresentativeCollom & Carney Clinic Association
SmithMalcolmPhysician/Voting Member14.28571429%ACO Participant RepresentativeCollom & Carney Clinic Association
TarpleyJonPhysician/Voting Member14.28571429%ACO Participant RepresentativeCollom & Carney Clinic Association
HallRogerCOO/Voting Member14.28571429%ACO Participant RepresentativeCollom & Carney Clinic Association
DwightMaryManager/Voting Member14.28571429%ACO Participant RepresentativeCollom & Carney Clinic Association
DurrantFayVoting Member14.28571429%Medicare Beneficiary RepresentativeN/A
 
  Key ACO clinical and administrative leadership:
 
Roger HallACO Executive
Joseph WomackMedical Director
Annette McGeeCompliance Officer
Belinda HuddlestonQuality Assurance/Improvement Officer
 
  Associated committees and committee leadership:
 
Committee NameCommittee Leader Name and Position
Quality and Clinical Informatics CommitteeMalcolm A. Smith, MD - Chair
Finance CommitteeGregory A. Richter, MD - Chair
Utilization Review CommitteeJoseph S. Womack, MD - Chair
 
  Types of ACO participants, or combinations of participants, that formed the ACO:
  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

  Shared Savings and Losses
  Amount of Shared Savings/Losses
  • N/A
 
  Shared Savings Distribution
  • N/A
 
  Quality Performance Results
  2016 Quality Performance Results:
 
ACO#Measure NameRateACO Mean
ACO-1CAHPS: Getting Timely Care, Appointments, and InformationN/A79.9
ACO-2CAHPS: How Well Your Providers CommunicateN/A92.63
ACO-3CAHPS: Patients' Rating of ProviderN/A91.93
ACO-4CAHPS: Access to SpecialistsN/A83.52
ACO-5CAHPS: Health Promotion and EducationN/A60
ACO-6CAHPS: Shared Decision MakingN/A75.28
ACO-7CAHPS: Health Status/Functional StatusN/A71.82
ACO-34CAHPS: Stewardship of Patient Resources N/A27.52
ACO-8Risk-Standardized, All Condition ReadmissionN/A14.7
ACO-35Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)N/A18.17
ACO-36All-Cause Unplanned Admissions for Patients with DiabetesN/A53.2
ACO-37All-Cause Unplanned Admissions for Patients with Heart FailureN/A75.23
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic ConditionsN/A59.81
ACO-9Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)N/A9.27
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )N/A14.53
ACO-11Percent of PCPs who Successfully Meet Meaningful Use RequirementsN/A82.72
ACO-39Documentation of Current Medications in the Medical RecordN/A87.54
ACO-13Falls: Screening for Future Fall RiskN/A64.04
ACO-14Preventive Care and Screening: Influenza ImmunizationN/A68.32
ACO-15Pneumonia Vaccination Status for Older AdultsN/A69.21
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow UpN/A74.45
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation InterventionN/A90.98
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up PlanN/A53.63
ACO-19Colorectal Cancer ScreeningN/A61.52
ACO-20Breast Cancer ScreeningN/A67.61
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-up DocumentedN/A76.84
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular DiseaseN/A77.72
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control N/A18.24
ACO-41Diabetes: Eye Exam N/A44.94
ACO-28Hypertension (HTN): Controlling High Blood PressureN/A70.52
ACO-30Ischemic Vascular Disease (IVD): Use of Aspirin or Another AntithromboticN/A85.05
ACO-31Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)N/A88.67
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)N/A79.67
 
  Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.
 
  Payment Rule Waivers
  • No, our ACO does not use the SNF 3-Day Rule Waiver.